While this technology would not be used in the specialty low-temperature processing facilities to be constructed and operated by BioExx, this does represent an opportunity for BioExx to leverage its Intellectual Property (IP) through licensees to rather simply and significantly increase the value of the meal produced in existing conventional facilities.

This value increase is enabled by the ability to process conventional meal, which is primarily sold as lower value animal feed, to produce Protein Concentrates which may sell for three to five times the price of meal.

The initial licensing focus of the Company will be on canola and rapeseed meal markets.  With 2007/08 crop year global production of conventional canola and rapeseed meal at 27.7 million metric tons (source: USDA), this represents a potentially significant and complementary new source of passive licensing revenue for BioExx over the medium to long term, in addition to the revenues from its core business of owning and operating high-value protein isolate production facilities.

Due to the fundamental limitations created by high temperature canola and rapeseed processing, the Protein Concentrates produced by this new method would be suitable only for use in specialty feed markets, and not suitable for the human-food Protein Isolate markets which are the core business and key focus of BioExx.  It is not possible with this technology to produce the higher-value BioExx Protein Isolates, which are a completely different product, with much higher purity, solubility, and a significantly different amino acid profile.

Although this new patent-pending process was created as an offshoot of the BioExx development work in that area, when these novel methods were modified for extension to standard toasted meal as an input, a high quality Protein Concentrate was created.

The product shows a strong nutritional profile, suitable for specialty feed applications, with low anti-nutritional factors and a mix of soluble and insoluble protein.

BioExx believes that the new process technology may be made available as a relatively simple retrofit onto the back end of conventional canola processing facilities, and with a capital and operating cost profile that would drive an attractive return on investment for licensees.

Without compromising its efforts on the primary business of constructing and operating additional and larger facilities to produce high-value protein isolates, BioExx plans to spend the next year working confidentially with selected licensees to fully develop this unique new technology, with a targeted initial commercialization within the next 24 months.   Licensing in this manner is also intended to enable deployment and revenue generation without any significant additional capital expenditure by BioExx.

“While we are very excited about this new development, we have no intention of letting it impair our very strong progress or our timetable for protein isolate production in Saskatoon.  Given that our team was able to complete this project in less than six months and at minimal cost, we see it as indicative of the broad reach of potential advancements that can and will be achieved through the application of our unique and growing portfolio of intellectual property,” said BioExx CEO, Chris Carl.

“Our team remains firmly committed to and highly confident in the successful commercialization of our protein isolate production in Saskatoon in mid Q1 2010, and all work in that regard is proceeding well and according to plan.”

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets.